ADDRESS:Shangma Industrial Development Area, Shitang Town, Wenling City, Zhejiang Province, China
1 Market capacity is gradually increasing
According to relevant research by the National Development and Reform Commission, it is estimated that by 2020, China's urbanization level will reach 58.5%. Urbanization will inevitably drive consumption growth, and the consumption concept and consumption demand of newcomers will undergo qualitative changes. Therefore, the safer, more reliable and more comfortable disposable sterile medical polymer products have huge consumption space. With the continuous improvement of people's living standards, the growing awareness of health, the deepening of urbanization and the increase of the proportion of aging, the market size of disposable medical polymer products will continue to grow.
In recent years, the continuous deepening of China's medical and health system reform and the continuous deepening of the medical system reform have laid a solid foundation for the realization of the national medical security system in the year. The improvement of the medical system drives the market demand for disposable medical polymer products.
In addition, with the development of prevention and control measures for epidemics and infectious diseases in the country, and with the economic and social development, the incidence of some non-communicable diseases has started to rise sharply due to changes in living environment and people's living habits. The rapid growth in the demand for medical polymer products has provided a broad growth space for disposable medical product manufacturers.
2 Domestic industry integration and upgrading is an inevitable trend
Although the total market for disposable polymer medical products in China continues to grow, the products are mainly concentrated in low-end popular products, and the benefits are not obvious. The homogenization and low-level production of domestic disposable sterile medical polymer products manufacturers are serious. It is easy for enterprises to form a vicious competition dominated by price wars. Some enterprises even occupy the market at or below the cost price. This short-sighted behavior is not conducive to the long-term development of the industry. At present, there are still a large number of family-type and workshop-type production enterprises in China's disposable medical polymer products industry. These enterprises have the characteristics of low scale and technical level, uneven production qualification, poor production environment, and unguaranteed product quality and after-sales service. . As labor costs and raw material prices continue to rise, industrial structure upgrades deepen, and some production enterprises that cannot form scale effects, production qualifications, and poor technical levels will lose their competitive advantage in the market. In addition, the external pressures and challenges brought by other industry enterprises in other emerging market countries such as Brazil and India cannot be ignored.
Therefore, in the future competition of the disposable medical polymer products industry, on the one hand, enterprises need to improve the competitive advantage of products, improve the grade of products through the application of new materials and new technologies, the improvement of product quality standards, and the improvement of processing technology. , jumping out of the homogenous competition at the low-level product level. On the other hand, there are many domestic production enterprises and small scales. However, according to the overall layout, the production areas are still relatively concentrated. This will lead to the establishment of orderly competition and reasonable division of labor and cooperation between enterprises to form a large-scale development of individual varieties. A higher requirement. In the future, disposable polymer medical product manufacturers need to reduce production costs by obtaining economies of scale. They also need to establish a medical consumables industry base to strengthen leading products, improve product reliability, safety and strengthen services for future development. Orientation can help improve the company's differentiated competitiveness and bargaining power in the market.
3 Enhancing product added value is the trend of industry development
Traditional disposable sterile medical polymer products usually use their physical properties to resist bacteria, prevent infection and alleviate the suffering of patients during treatment, surgery or nursing. These characteristics mainly depend on the physical properties of the materials used and The control of the production process is achieved. With the development of clinical medicine, combining drugs with traditional medical polymer products is an important trend in the development of disposable sterile medical polymer products industry. For example, in wounds and wound care, dressings that have just entered the clinical application field with trace elements that have targeted repair effects on damaged cells and promote cell regeneration, such as alginate biological dressings and other pharmaceutical ingredients. Dressing, etc. Compared with traditional dressings, these dressings not only play a traditional role in creating a sterile environment for wounds and preventing wound infection, but also promote epithelial cell regeneration, inhibit excessive growth of granulation tissue, and finally reduce wound scars and promote wounds on wound sites. The effect of healing. With the continuous improvement of people's treatment and nursing requirements, the intensified competition in the industry, and the strong desire of enterprises to differentiate their competition and break the current low-quality and homogenized competition in the market, this treatment will be treated with medical products. The combination of measures to increase the added value of products will become an important trend in the future development of the disposable sterile medical products industry.
4 Integrate circulation links to reduce circulation costs
The price of medical devices is so high that the problem is not mainly in the production process, but the virtual high is mainly generated in the circulation. In general, medical consumables from the manufacturer to the hospital, usually through a level of agency, regional agents, provincial agents and other levels, each transfer at least 30% of the profit bonus.
According to the investigation report of the Guangdong Provincial Price Bureau, 89% of the hospitals surveyed mainly purchased medical consumables from wholesale enterprises, and 11% of the hospitals purchased from wholesale enterprises and production enterprises at the same time, that is, most medical consumables. It is necessary to go through the intermediate link of the wholesaler, and the mark-up rate and the mark-up rate in the circulation field lack effective supervision. At the same time, the report shows that in the middle circulation, high-value medical consumables in Guangdong Province are generally sold from the factory (or imported) to medical institutions, with an average price increase of 2-3 times, and individual products even as many as ten times. These medical consumables have been changed hands and increased in layers, and the high price has seriously damaged the interests of patients (Source: Guangdong Provincial Price Bureau Research Report on Medical Consumables (2011)).
Since the issuer entered the disposable medical products industry, it has begun to build a nationwide sales platform and medical logistics network, and directly establish supply relations with major hospitals around the country. Through a wide-ranging sales network, the problem of the high price of products due to distribution channels is avoided, and a brand image with high quality and low price is established in hospitals and patients.
5 reduce the risk of infection and improve the quality and safety of medical services
At present, the hospital infection control rate has become an important indicator in the hospital evaluation system. In the early days, mainly foreign disposable medical products companies rely on their close cooperation with medical staff around the world and full understanding of the diagnosis and treatment procedures, through its coverage of medical treatment, surgical procedures, disposable medical care, Protective products reduce the risk of infection for health care workers and patients. However, due to the high price of foreign products, the cost of medical care has increased. In China, cost control is an important factor to be considered in the management of patients and hospitals. Especially in most of the relatively underdeveloped areas in China, it is impossible to popularize all-round medical treatment in all aspects of clinical use through large-scale application of disposable medical products. Anti-infective measures.
In the period when the issuer was established and then for a long period of time, China's medical consumables industry mainly relied on family-style and workshop-style production, which was characterized by low scale and technical level of producers, uneven production qualifications and relatively stable production environment. Poor and product quality and after-sales service can not be guaranteed, and the resulting hospital infection rate and medical accidents have been at a high level. Hospital infections and complications not only affect the postoperative rehabilitation and life safety of patients, but also cause additional medical expenses for patients and hospitals, which will bring huge economic burden and waste of medical resources to patients and society. The concentrated outbreak of hospital infections may even occur. Affect social stability. The control of hospital infection rate by hospitals and medical institutions at all levels has provided the impetus for the growth of disposable medical polymer products market.